Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GoodSense is a leading brand of over-the-counter (OTC) healthcare products, providing affordable alternatives to name-brand medications. Originally the flagship brand of Geiss, Destin & Dunn, Inc., it was acquired by Perrigo Company plc in 2013. The product line includes a wide range of medications for pain relief, allergy management, digestive health, and cough/cold symptoms. GoodSense products are manufactured to meet FDA standards for safety and efficacy, mirroring the active ingredients of national brands. The company focuses on the value-conscious consumer segment within the retail pharmacy and grocery sectors. Its portfolio is widely distributed across major US retailers and e-commerce platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GoodSense.